Am Investment Strategies LLC Abb Vie Inc. Transaction History

Am Investment Strategies LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$154.79 - $180.76 $130,952 - $152,922	-846 Reduced 16.04%	4,429 $759,000
Q1 2024 May 02, 2024	BUY	$159.82 - $182.1 $27,968 - $31,867	175 Added 3.43%	5,275 $960,000
Q4 2023 Feb 02, 2024	BUY	$137.6 - $154.97 $113,520 - $127,850	825 Added 19.3%	5,100 $790,000
Q2 2023 Jul 26, 2023	BUY	$132.51 - $164.9 $83,348 - $103,722	629 Added 17.25%	4,275 $576,000
Q1 2023 Apr 21, 2023	SELL	$144.61 - $166.54 $41,647 - $47,963	-288 Reduced 7.32%	3,646 $581,000
Q4 2022 Feb 03, 2023	BUY	$138.31 - $165.87 $7,192 - $8,625	52 Added 1.34%	3,934 $636,000
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $60,126 - $68,960	448 Added 13.05%	3,882 $521,000
Q2 2022 Jul 21, 2022	SELL	$137.62 - $174.96 $13,762 - $17,496	-100 Reduced 2.83%	3,434 $526,000
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $1,583 - $1,965	12 Added 0.34%	3,534 $573,000
Q4 2021 Feb 02, 2022	SELL	$107.43 - $135.93 $16,544 - $20,933	-154 Reduced 4.19%	3,522 $477,000
Q3 2020 Oct 27, 2020	BUY	$85.91 - $100.83 $315,805 - $370,651	3,676 New	3,676 $322,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Am Investment Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Am Investment Strategies LLC with notifications on news.